Paul A. Randell
St George's University Of London
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Timing of Loss of Transplacental Antibodies in Infants Born to Mothers Living With Human T-cell Lymphotropic Virus Type 1.
Journal: The Pediatric infectious disease journal
Published: August 13, 2026
British Association of Sexual Health and HIV guidelines on the management of viral hepatitis 2026.
Journal: International journal of STD & AIDS
Published: May 12, 2026
Value of targeted testing for cytomegalovirus in preterm infants: 7 years' experience at a tertiary London hospital.
Journal: Archives of disease in childhood. Fetal and neonatal edition
Published: June 01, 2025
Reduced risk for Omicron SARS-CoV-2 infection observed in older adults with hybrid immunity.
Journal: Age and ageing
Published: January 28, 2024
Managing mpox using a remote monitoring service.
Journal: The Journal of infection
Published: May 17, 2023
Hybrid immunity in older adults is associated with reduced SARS-CoV-2 infections following BNT162b2 COVID-19 immunisation.
Journal: Communications medicine
Published: November 24, 2022
Use of cidofovir in a patient with severe mpox and uncontrolled HIV infection.
Journal: The Lancet. Infectious diseases
Published: November 22, 2022
Characterization of Rare Spontaneous Human Immunodeficiency Virus Viral Controllers Attending a National United Kingdom Clinical Service Using a Combination of Serology and Molecular Diagnostic Assays.
Journal: Open forum infectious diseases
Published: November 10, 2022
SARS-CoV-2 surface and air contamination in an acute healthcare setting during the first and second pandemic waves.
Journal: The Journal of hospital infection
Published: September 01, 2022
Rapid reconfiguration of sexual health services in response to UK autochthonous transmission of mpox (monkeypox).
Journal: Sexually transmitted infections
Published: June 24, 2022
Early identification of high-risk individuals for monoclonal antibody therapy and prophylaxis is feasible by SARS-CoV-2 anti-spike antibody specific lateral flow assay.
Journal: Diagnostic microbiology and infectious disease
Published: June 10, 2022
Last Updated: 09/26/2026